Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × darolutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Biochemically Recurrent Prostate Cancer 2 Urogenital Neoplasms 1 Urogenital Diseases 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Non-metastatic Castration-resistant Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Male Urogenital Diseases 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Tamoxifen 6 Specimen Handling 4 exemestane 3 Letrozole 3 Anastrozole 3 Biopsy 2 poly ICLC 1 fezolinetant 1 elacestrant 1 Testosterone 1 Surveys and Questionnaires 1 Selective Estrogen Receptor Modulators 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Multicenter Studies as Topic 1 Medicare 1 Mastectomy, Segmental 1 Mastectomy 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Diet Records 1 Colony-Stimulating Factors 1 CD2-associated protein 1 Blood Specimen Collection 1 Aromatase Inhibitors 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡